Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study

BACKGROUND: Multiple guidelines for pancreatic ductal adenocarcinoma (PDAC) suggest that all stages of patients need to receive postoperative adjuvant chemotherapy. S-1 is a recently emerged oral antitumour agent recommended by the guidelines. However, which population would benefit from S-1 needs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Liang, Ding, Ying, Yu, Yiyi, Liu, Kai, Rao, Shengxiang, Ge, Yingqian, Zeng, Mengsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077911/
https://www.ncbi.nlm.nih.gov/pubmed/33902469
http://dx.doi.org/10.1186/s12880-021-00605-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077911/
https://www.ncbi.nlm.nih.gov/pubmed/33902469
http://dx.doi.org/10.1186/s12880-021-00605-4

Ejemplares similares